Gernert, Michael https://orcid.org/0000-0003-0074-4459
Tony, Hans-Peter
Schwaneck, Eva Christina
Fröhlich, Matthias
Schmalzing, Marc
Article History
Received: 15 April 2020
Accepted: 18 June 2020
First Online: 8 August 2020
Ethics approval and consent to participate
: This study was a retrospective cohort study, which is why approval by the local ethics committee of the University of Würzburg was not mandatory. Solely routine parameters (for a tertiary referral center) were implemented in this analysis, which is why obtaining informed consent was not necessary according to German law. All data was generated in compliance with the Declaration of Helsinki.
: Not applicable.
: MG received travel grants from AbbVie, Chugai, Eli Lilly, Hexal, Janssen, Pfizer, and Roche.H-PT received speaker’s fees, travel grants, research funding, or compensation for consultancies or board memberships from AbbVie, Chugai/Roche, Eli Lilly, Gilead, Janssen, Novartis, Sandoz/Hexal, Sanofi Aventis, and Takeda (Shire).ECS received speaker’s fees, travel grants, research funding, or compensation for consultancies or board memberships from AbbVie, Chugai/Roche, Janssen-Cilag, Eli Lilly, Novartis, and Takeda (Shire).MF received travel grants from AbbVie, Novartis, Janssen, and Eli Lilly and compensation for board memberships from AbbVie.MS received speaker’s fees, travel grants, research funding, or compensation for consultancies or board memberships from AbbVie, Actelion, BMS, Boehringer/Ingelheim, Celgene, Chugai/Roche, Eli Lilly, Genzyme, Gilead, Hexal/Sandoz, Janssen-Cilag, MSD, Novartis, Pfizer, Sanofi Pasteur, Takeda (Shire), and UCB.